Diabetes and Oral Health: The Two-Way Relationship Explained

Originally published April 2026 · Updated May 2026 with the June 2025 Frontiers in Nutrition narrative review on HbA1c and the bidirectional periodontitis–diabetes relationship.

Oral health has traditionally been treated as a separate domain from systemic medicine. Teeth and gums sit in dentistry. Blood sugar and metabolism sit in endocrinology. The two rarely appear in the same conversation — and when they do, the relationship is usually framed in one direction: diabetes causes oral health problems.

The evidence now tells a considerably more complex and clinically important story. Gum disease does not just occur more frequently in people with diabetes. It actively worsens blood sugar control. And treating gum disease produces measurable improvements in HbA1c — the primary clinical marker of long-term glucose management — comparable to the effect of adding a second diabetes medication.

A June 2025 narrative review published in Frontiers in Nutrition examined the role of HbA1c in the bidirectional relationship between periodontitis and diabetes, summarising the mechanisms and interventions across the current evidence base. Here is what it found — and what it means practically.

TL;DR

• People with poorly controlled diabetes are three times more likely to develop severe periodontal disease than people without diabetes — due to impaired immune function, elevated glucose in gingival fluid, and altered blood vessel function.
• Periodontal disease actively worsens glycaemic control through systemic inflammation that drives insulin resistance — creating a self-reinforcing cycle.
• A June 2025 Frontiers in Nutrition review confirmed that HbA1c links periodontitis and diabetes bidirectionally — elevated HbA1c worsens periodontal disease and periodontal disease elevates HbA1c.
• Non-surgical periodontal therapy reduces HbA1c by 0.2 to 0.4% — a clinically significant reduction roughly equivalent to adding a second medication to a diabetes regimen.
• The oral microbiome in people with diabetes shows consistent dysbiosis — with elevated Porphyromonas gingivalis and other periodontal pathogens — that both results from and contributes to poor glycaemic control.
• Dry mouth — common in diabetes — creates a cascade of secondary oral health problems that most people with diabetes are not adequately warned about.

The Bidirectional Relationship: What It Means

Bidirectional means the relationship runs in both directions simultaneously — not just diabetes causing oral problems, but oral problems actively worsening diabetes.

This distinction matters clinically because it creates a self-reinforcing cycle that, if not interrupted, allows both conditions to progress simultaneously. Understanding why requires understanding what each condition does to the other.

How Diabetes Affects the Mouth

Elevated blood glucose — the defining feature of diabetes — affects oral health through multiple converging mechanisms.

Impaired Immune Response

High blood glucose impairs the function of neutrophils — the white blood cells that form the first line of defence against oral bacteria. Neutrophil chemotaxis, phagocytosis, and intracellular killing are all reduced in people with poorly controlled diabetes. This means that the bacterial communities in dental plaque face less effective immune surveillance, allowing periodontal pathogens to establish and flourish more readily.

The elevated glucose environment also enhances bacterial virulence — several periodontal bacteria, including Porphyromonas gingivalis, demonstrate increased adhesion and colonisation capacity in high-glucose conditions.

Elevated Glucose in Gingival Fluid

The fluid that bathes the gingival sulcus — the space between tooth and gum — reflects blood glucose concentrations. In people with poorly controlled diabetes, this fluid contains elevated glucose that provides a rich nutrient substrate for bacterial growth. This creates a local environment that specifically favours the growth of periodontal pathogens over commensal bacteria — shifting the oral microbiome toward dysbiosis.

Vascular and Wound Healing Impairment

Diabetes causes microvascular changes that reduce blood supply to gingival tissue. This impairs the delivery of immune cells and oxygen to the periodontium and slows the tissue repair and healing responses that would normally limit periodontal disease progression. Once periodontal pockets form, they heal more slowly in people with diabetes — and the impaired healing creates a more favourable environment for disease progression.

Advanced Glycation End Products

Chronic hyperglycaemia produces advanced glycation end products — AGEs — through the non-enzymatic glycation of proteins. AGEs interact with receptors on macrophages and endothelial cells in the gingival tissue, triggering enhanced inflammatory responses that contribute to periodontal tissue destruction. This mechanism links blood sugar control directly to the rate of periodontal bone loss.

How Gum Disease Worsens Diabetes: The Reverse Direction

This is the direction of the relationship that is less widely understood — and more clinically underappreciated.

Periodontal disease is not a localised infection that stays in the mouth. It is a chronic inflammatory condition with systemic consequences.

Systemic Inflammation and Insulin Resistance

Deep periodontal pockets harbour billions of bacteria that continuously release lipopolysaccharides and other bacterial toxins into the gingival tissue. The immune response to this bacterial challenge produces a sustained release of pro-inflammatory cytokines — primarily TNF-α and IL-6 — that enter systemic circulation.

This is the critical link to diabetes. TNF-α and IL-6 are direct drivers of insulin resistance — they impair insulin receptor signalling, reduce glucose uptake in muscle and fat cells, and promote hepatic glucose production. Sustained periodontal inflammation therefore maintains a systemic inflammatory state that continuously worsens insulin resistance and makes blood glucose harder to control.

The June 2025 Frontiers in Nutrition review confirmed this mechanism as central to the bidirectional relationship — identifying suppression of anti-inflammatory and antidiabetic control mechanisms as one of the primary ways in which periodontitis drives worsening glycaemic control.

HbA1c as the Connecting Biomarker

HbA1c — glycated haemoglobin — reflects average blood glucose over the preceding two to three months. The June 2025 review found that HbA1c links periodontitis and diabetes bidirectionally — elevated HbA1c contributes to worse periodontal disease, and periodontal disease elevates HbA1c through the systemic inflammation mechanism.

Several mechanism theories have been proposed, including alterations in oral flora, suppression of anti-inflammatory and antidiabetic control mechanisms in periodontitis, gene silencing due to reduced DNA demethylation, and significantly lower quantitative levels of platelet-rich fibrin.

This creates the self-reinforcing cycle that defines the bidirectional relationship: poor glycaemic control worsens periodontal disease, which increases systemic inflammation, which worsens insulin resistance, which worsens glycaemic control.

The Oral Microbiome Link

The oral microbiome in people with diabetes consistently shows dysbiosis — a shift in bacterial community composition toward periodontal pathogens and away from commensal protective species.

Porphyromonas gingivalis — the primary periodontal pathogen — has been found in atherosclerotic plaques, liver tissue, and other systemic sites in people with advanced periodontal disease, suggesting that oral bacteria can translocate beyond the mouth and contribute to systemic pathology. P. gingivalis specifically impairs insulin signalling and has been found to promote systemic insulin resistance in animal models — providing a direct bacterial link between periodontal infection and diabetes pathophysiology.

What Treating Gum Disease Does to Blood Sugar

The most clinically significant evidence in this field is what happens when periodontal disease is treated in people with diabetes.

Studies have shown that periodontal treatment can lower HbA1c levels from 0.2% to 0.4%. Although this reduction may appear modest, it is considered clinically significant in the context of diabetes management. The reduction is roughly the same as adding a second medication to your daily regimen.

This finding — replicated across multiple randomised controlled trials and confirmed in systematic reviews — is one of the most practically important in the diabetes-oral health literature. It means that dental treatment has a measurable and clinically relevant effect on diabetes management that most endocrinologists and GPs do not routinely discuss with patients.

Non-surgical periodontal therapy — scaling and root planing to remove subgingival bacteria and calculus — is the standard treatment producing this effect. It works by reducing the bacterial load and inflammatory burden that drives systemic TNF-α and IL-6 elevation, allowing the systemic inflammatory state to partially resolve and insulin sensitivity to improve.

The June 2025 review also examined adjunctive therapies that enhance the effect of periodontal treatment in people with diabetes — including systemic antibiotics, propolis, and antimicrobial photodynamic therapy. The last is particularly interesting: indocyanine green-based photodynamic therapy, which uses light-activated antimicrobial agents to target bacteria in periodontal pockets, is receiving increasing research attention as an adjunct that may produce additional HbA1c reduction beyond scaling alone.

Dry Mouth: The Underappreciated Complication

Dry mouth — xerostomia — is one of the most common oral manifestations of diabetes and one of the least discussed. It affects approximately 40 to 50% of people with diabetes and operates through several mechanisms that compound oral health risk.

Autonomic neuropathy — nerve damage to the salivary glands from chronic hyperglycaemia — reduces saliva production. Certain diabetes medications, including some antihypertensives, diuretics, and antidepressants commonly used in people with diabetes, further reduce salivary flow as a side effect.

Saliva is the mouth's primary defence system — it clears bacteria, buffers acids, remineralises enamel, and maintains the pH environment that inhibits pathogenic species. When salivary flow is chronically reduced, the protective environment is lost and the risk of tooth decay, oral candidiasis, and periodontal disease all increase simultaneously.

The consequences compound: dry mouth increases decay risk, decay increases bacterial load, bacterial load worsens periodontal disease, and periodontal disease worsens glycaemic control. For people with diabetes and dry mouth, this cascade is a meaningful and often unaddressed contributor to progressive oral and systemic health deterioration.

Practical interventions for dry mouth in diabetes: consistent hydration throughout the day, alcohol-free oral rinses and salivary substitutes, sugar-free xylitol-containing gum or lozenges to stimulate salivary flow, and review of medications with a GP or pharmacist to identify any that can be modified.

The Oral Microbiome in Diabetes: What's Different

The oral microbiome of people with diabetes shows consistent and characteristic changes that distinguish it from the microbiome of people without diabetes.

Beyond the elevation of P. gingivalis, studies have identified increased abundance of Treponema denticola, Tannerella forsythia, and other members of the "red complex" of periodontal pathogens — the bacteria most strongly associated with severe periodontal disease — in people with poorly controlled diabetes. There is also a consistent reduction in beneficial commensal species that would normally compete with periodontal pathogens for space and nutrients.

The elevated glucose in the oral environment drives this dysbiosis directly — providing selectively enriched substrate for glucose-fermenting and acid-tolerant species that thrive in the altered oral environment of diabetes. This creates a situation where improving glycaemic control is not just beneficial for systemic health but directly therapeutic for the oral microbiome — reducing the glucose that fuels the dysbiotic shift.

Practical Implications: What This Means for People With Diabetes

The bidirectional evidence has several practical implications that are not yet routinely integrated into diabetes care in the UK:

Dental care is part of diabetes management. A 0.2 to 0.4% HbA1c reduction from periodontal treatment is a clinically meaningful intervention in diabetes management — comparable to the effect of pharmacological interventions. People with diabetes should be encouraged to seek dental care proactively and regularly, and GPs and diabetes nurses should be routinely asking about dental health as part of diabetes review.

Three to four monthly dental maintenance. The American Dental Association guidelines suggest that periodontal maintenance be performed every three to four months for people with diabetes — more frequent than the standard six-monthly recall — because diabetic patients are more prone to infection and heal more slowly.

Disclose diabetes status to your dentist. A dentist aware of a patient's diabetes diagnosis and current HbA1c can tailor treatment planning, healing expectations, infection risk management, and recall frequency accordingly. This information is clinically relevant and routinely underreported in dental consultations.

Dry mouth management is not optional. Xerostomia in diabetes is a direct contributor to oral health deterioration and should be actively managed rather than accepted as inevitable.

Blood sugar control supports oral healing. Any dental procedure — from scaling to extraction — heals more slowly in poorly controlled diabetes. Optimising glycaemic control before planned dental procedures reduces complication risk and supports better healing outcomes.

Frequently Asked Questions

Does diabetes cause gum disease?

Yes — people with poorly controlled diabetes are approximately three times more likely to develop severe periodontal disease than people without diabetes. Elevated blood glucose impairs immune function, increases glucose in gingival fluid that feeds periodontal bacteria, impairs blood vessel function and wound healing, and produces advanced glycation end products that drive gingival inflammation. The risk is dose-dependent — poorer glycaemic control is associated with more severe periodontal disease.

Can gum disease make diabetes worse?

Yes — this is the less widely understood direction of the bidirectional relationship. Periodontal disease produces chronic systemic inflammation through sustained release of TNF-α and IL-6, which directly drive insulin resistance and impair blood glucose control. Treating periodontal disease reduces HbA1c by 0.2 to 0.4% in clinical trials — a clinically significant reduction equivalent to adding a second diabetes medication.

What does periodontal treatment do to HbA1c?

A June 2025 Frontiers in Nutrition narrative review confirmed that non-surgical periodontal therapy reduces HbA1c by 0.2 to 0.4% in people with diabetes. This reduction works by reducing the bacterial load and inflammatory burden that drives systemic TNF-α and IL-6 elevation — allowing systemic inflammation to partially resolve and insulin sensitivity to improve. The effect is most pronounced in people with poorly controlled diabetes at baseline.

Why do people with diabetes get dry mouth?

Dry mouth in diabetes results from autonomic neuropathy — nerve damage to the salivary glands from chronic hyperglycaemia — alongside the side effects of many medications commonly used in people with diabetes. Reduced saliva removes the mouth's primary defence against bacteria, acids, and infections, significantly increasing risk of tooth decay, oral candidiasis, and periodontal disease. Active management through hydration, salivary substitutes, and xylitol-containing gum is important.

How often should people with diabetes see a dentist?

American Dental Association guidelines recommend periodontal maintenance every three to four months for people with diabetes — more frequent than the standard six-monthly recall — because of increased infection risk and slower healing. In the UK, dental recall intervals are typically set by the individual dentist based on assessed risk. People with diabetes should make sure their dentist is aware of their condition so that recall frequency can be appropriately calibrated.

What bacteria are involved in the diabetes-gum disease link?

The key periodontal pathogens elevated in people with diabetes include Porphyromonas gingivalis — the primary pathogen in severe periodontal disease — alongside Treponema denticola and Tannerella forsythia. P. gingivalis specifically has been found to impair insulin signalling and promote systemic insulin resistance in animal models, and has been detected in atherosclerotic plaques and other systemic sites, suggesting a direct bacterial pathway between oral infection and systemic metabolic disease.

The Bottom Line

The relationship between diabetes and oral health is genuinely bidirectional — and the clinical implications of recognising this are significant. Gum disease is not just a complication of diabetes. It is an active driver of worsening glycaemic control that, if treated, can produce measurable improvements in HbA1c comparable to pharmacological intervention.

For people with diabetes, oral health is not a cosmetic concern or a secondary consideration. It is a modifiable determinant of how well their diabetes is controlled. And for anyone whose gum disease is being managed without reference to their blood sugar status — or whose diabetes is being managed without reference to their oral health — something important is being missed.

For a structured approach to oral health as part of broader metabolic wellbeing, the Gut Reset from the Reset Series™ covers the systemic inflammation and microbiome foundations most relevant to the oral-metabolic connection. The Sugar Reset addresses the dietary pattern most directly implicated in both blood sugar dysregulation and oral dysbiosis. Pair either with the Reset Companion for daily guidance, or explore the full Reset Series bundle.

Related reading: Stop Using Mouthwash Every Day. Here's Why. · Vaping and Bad Breath: What the Science Actually Shows · Understanding MASLD — and How to Support a Healthier Liver

Popular Articles